0001209191-18-064233.txt : 20181228 0001209191-18-064233.hdr.sgml : 20181228 20181228084049 ACCESSION NUMBER: 0001209191-18-064233 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181227 FILED AS OF DATE: 20181228 DATE AS OF CHANGE: 20181228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DIGIANDOMENICO ANTHONY CENTRAL INDEX KEY: 0001083544 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 181256061 MAIL ADDRESS: STREET 1: 3600 GREEN COURT, SUITE 350 CITY: ANN ARBOR STATE: MI ZIP: 48105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 W. KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 675 W. KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-12-27 0 0001645460 Cue Biopharma, Inc. CUE 0001083544 DIGIANDOMENICO ANTHONY 2425 CEDAR SPRINGS ROAD DALLAS TX 75201 1 0 0 0 Common Stock 2018-12-27 4 P 0 20000 4.77 A 50000 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.63 to $4.93, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4 Shares are held jointly with the reporting person's spouse. /s/ Anthony DiGiandomenico by Mark R. Busch, attorney-in-fact 2018-12-28